1442. Deputy Matt Carthy asked the Minister for Health the number of patients estimated to be eligible for treatment with skyclarys (omaveloxolone); if additional clinical appointments or resources are being provided to the National Ataxia Clinic at Tallaght University Hospital or other relevant services to facilitate the assessment and treatment of eligible patients; whether any capacity constraints that could delay access to the medication have been identified; and if she will make a statement on the matter. [65856/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.